The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the ...
Google’s AI arm led by Demis Hassabis makes it harder for its researchers to publish studies in major change in approach ...
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Demis, who was last year jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their ...
It was a bold choice to host a preview screening of The Thinking Game, a documentary about AI company Google DeepMind and its ...
Demis Hassabis, Elon Musk, and Sam Altman have all warned that artificial general intelligence (AGI) will outwit humans in the near future.
AI is already changing how we work with computers, but it might also change how we interact with the human body. Demis ...